 |
|
Chronic Cutaneous Lupus ErythematosusThalidomide Treatment of 11 Patients
Marja F. Hasper, MD
Arch Dermatol. 1983;119(10):812-815.
Abstract
• Eleven patients with severe, chloroquine-resistant chronic cutaneous lupus erythematosus were treated with oral thalidomide. Seven patients responded with a complete remission, and two patients' conditions improved significantly. One patient did not respond well to therapy and another patient had to be withdrawn from the treatment trial because of side effects. Six patients, who relapsed after discontinuing thalidomide treatment, were re-treated with maintenance drug dosages and achieved good results with no further relapses or exacerbations. In all subjects the side effects from the thalidomide were minor and reversible.
(Arch Dermatol 1983;119:812-815)
Author Affiliations
From the Department of Dermatology, University of Groningen (the Netherlands).
Footnotes
Accepted for publication Oct 5, 1982.
Reprint requests to Department of Dermatology, University Hospital, 9700 RB Groningen, the Netherlands (Dr Hasper).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
American Experience With Low-Dose Thalidomide Therapy for Severe Cutaneous Lupus Erythematosus
Duong et al.
Arch Dermatol 1999;135:1079-1087.
ABSTRACT
| FULL TEXT
The place of thalidomide in the treatment of inflammatory disease
Stevens
Lupus 1996;5:257-258.
Successful Treatment of Adult's Langerhans Cell Histiocytosis With Thalidomide: Report of Two Cases and Literature Review
Thomas et al.
Arch Dermatol 1993;129:1261-1264.
ABSTRACT
Review: Treatment of Cutaneous Lupus Erythematosus
Rothe and Kerdel
Lupus 1992;1:351-356.
ABSTRACT
|
